131 related articles for article (PubMed ID: 24085767)
1. Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation.
Nuzzo F; Radu C; Baralle M; Spiezia L; Hackeng TM; Simioni P; Castoldi E
Blood; 2013 Nov; 122(23):3825-31. PubMed ID: 24085767
[TBL] [Abstract][Full Text] [Related]
2. Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency.
Nuzzo F; Bulato C; Nielsen BI; Lee K; Wielders SJ; Simioni P; Key NS; Castoldi E
Haemophilia; 2015 Mar; 21(2):241-248. PubMed ID: 25470420
[TBL] [Abstract][Full Text] [Related]
3. Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma.
Castoldi E; Duckers C; Radu C; Spiezia L; Rossetto V; Tagariello G; Rosing J; Simioni P
J Thromb Haemost; 2011 May; 9(5):959-68. PubMed ID: 21320286
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing pattern.
Dall'Osso C; Guella I; Duga S; Locatelli N; Paraboschi EM; Spreafico M; Afrasiabi A; Pechlaner C; Peyvandi F; Tenchini ML; Asselta R
Haematologica; 2008 Oct; 93(10):1505-13. PubMed ID: 18728029
[TBL] [Abstract][Full Text] [Related]
5. In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency.
Todaro AM; Radu CM; Ciccone M; Toffanin S; Serino ML; Campello E; Bulato C; Lunghi B; Gemmati D; Cuneo A; Hackeng TM; Simioni P; Bernardi F; Castoldi E
J Thromb Haemost; 2024 Feb; 22(2):410-422. PubMed ID: 37866515
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Impact of Aberrant Splicing in Coagulation Factor V Deficiency.
Paraboschi EM; Menegatti M; Peyvandi F; Duga S; Asselta R
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791524
[TBL] [Abstract][Full Text] [Related]
7. High-level expression of hemoglobin A in human thalassemic erythroid progenitor cells following lentiviral vector delivery of an antisense snRNA.
Vacek MM; Ma H; Gemignani F; Lacerra G; Kafri T; Kole R
Blood; 2003 Jan; 101(1):104-11. PubMed ID: 12393543
[TBL] [Abstract][Full Text] [Related]
8. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
Davis RL; Homer VM; George PM; Brennan SO
Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
[TBL] [Abstract][Full Text] [Related]
9. Double-target antisense U7 snRNAs promote efficient skipping of an aberrant exon in three human beta-thalassemic mutations.
Suter D; Tomasini R; Reber U; Gorman L; Kole R; Schümperli D
Hum Mol Genet; 1999 Dec; 8(13):2415-23. PubMed ID: 10556289
[TBL] [Abstract][Full Text] [Related]
10. Engineered U7 snRNA mediates sustained splicing correction in erythroid cells from β-thalassemia/HbE patients.
Preedagasamzin S; Nualkaew T; Pongrujikorn T; Jinawath N; Kole R; Fucharoen S; Jearawiriyapaisarn N; Svasti S
Biochem Biophys Res Commun; 2018 Apr; 499(1):86-92. PubMed ID: 29550480
[TBL] [Abstract][Full Text] [Related]
11. High incidence of intracranial bleeding in factor V-deficient patients with homozygous F5 splicing mutations.
Nuzzo F; Beshlawi I; Wali Y; Castoldi E
Br J Haematol; 2017 Oct; 179(1):163-166. PubMed ID: 27351627
[No Abstract] [Full Text] [Related]
12. Functional correction by antisense therapy of a splicing mutation in the GALT gene.
Coelho AI; Lourenço S; Trabuco M; Silva MJ; Oliveira A; Gaspar A; Diogo L; Tavares de Almeida I; Vicente JB; Rivera I
Eur J Hum Genet; 2015 Apr; 23(4):500-6. PubMed ID: 25052314
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of factor V mRNA to define the residual factor V expression levels in severe factor V deficiency.
Lunghi B; Pinotti M; Maestri I; Batorova A; Bernardi F
Haematologica; 2008 Mar; 93(3):477-8. PubMed ID: 18310546
[TBL] [Abstract][Full Text] [Related]
14. Ser234Leu missense mutation in the A1 domain of factor V causing moderate factor V deficiency in a Chinese family.
Jin PP; Wang XF; Ding QL; Fu QH; Cai XH; Shen LS; Wang HL
Pathology; 2009; 41(6):566-71. PubMed ID: 19900106
[TBL] [Abstract][Full Text] [Related]
15. Antisense Oligonucleotide-Based Splice Correction of a Deep-Intronic Mutation in CHM Underlying Choroideremia.
Garanto A; van der Velde-Visser SD; Cremers FPM; Collin RWJ
Adv Exp Med Biol; 2018; 1074():83-89. PubMed ID: 29721931
[TBL] [Abstract][Full Text] [Related]
16. Arg2074Cys missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein.
Duga S; Montefusco MC; Asselta R; Malcovati M; Peyvandi F; Santagostino E; Mannucci PM; Tenchini ML
Blood; 2003 Jan; 101(1):173-7. PubMed ID: 12393490
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterisation of Tyr530Ser and IVS16-1G>T mutations causing severe factor V deficiency.
Zheng W; Liu Y; Luo Y; Chen Z; Wang Y; Zhang L; Gao G; Yao Z
Thromb Haemost; 2010 Sep; 104(3):536-43. PubMed ID: 20664902
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of a novel missense mutation identified in a Turkish patient affected by severe coagulation factor V deficiency.
Paraboschi EM; Kayiran SM; Özbek N; Gürakan B; Peyvandi F; Guella I; Duga S; Asselta R
Haemophilia; 2012 Mar; 18(2):205-10. PubMed ID: 21777354
[TBL] [Abstract][Full Text] [Related]
19. Factor V deficiency.
Asselta R; Peyvandi F
Semin Thromb Hemost; 2009 Jun; 35(4):382-9. PubMed ID: 19598066
[TBL] [Abstract][Full Text] [Related]
20. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency.
van Wijk R; Nieuwenhuis K; van den Berg M; Huizinga EG; van der Meijden BB; Kraaijenhagen RJ; van Solinge WW
Blood; 2001 Jul; 98(2):358-67. PubMed ID: 11435304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
